HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China

HUYA Bioscience International Establishes Strategic Partnership with School of
Medicine and Pharmacy, Ocean University of China

SAN DIEGO, Nov. 9 /PRNewswire/ -- HUYA Bioscience International, a leader in
globalizing China's biopharmaceutical innovation, today announced a strategic
partnership with the School of Medicine and Pharmacy, Ocean University of
China. The agreement is another in a series of collaborations that HUYA has
established with China's leading research and development institutions to
enable and accelerate the global development and commercialization of novel
biopharmaceutical product opportunities originating in China.

HUYA is one of the first companies to have recognized China's potential to
help meet the global need for new pre-clinical and clinical stage compounds.
The agreement with Ocean University of China provides HUYA with rights of
first review and negotiation relating to certain novel therapeutic and
diagnostic product candidates owned or controlled by the University. In
return, Ocean University of China gains access to HUYA's global network of
pharmaceutical partners and its expertise in pre-clinical and clinical
development.

"Ocean University is one of China's leading institutions, with considerable
expertise in the field of marine pharmaceutical science," said Michael Newman,
Ph.D., Executive Vice President of Oncology at HUYA Bioscience. "We look
forward to collaborating with this prestigious university to bring novel
biopharmaceutical products to the global marketplace."

"Ocean University is committed to strengthening its research programs in
marine pharmaceutical science," said Qiangming Wu, Ph.D., Executive Dean,
School of Medicine and Pharmacy, Ocean University of China. "We are pleased to
partner with HUYA's expert team to achieve this objective."

ABOUT HUYA
HUYA is the leader in global pharmaceutical co-development with China. With
six strategic offices in China, the broadest Chinese compound portfolio, and
more exclusive agreements with premier Chinese biotech centers than any other
company, HUYA has pioneered the most innovative and productive approach to
pharmaceutical co-development between the U.S. and China. HUYA has joint
headquarter offices in San Diego, CA, and Shanghai. Additional information
about the company is available at www.huyabio.com.

ABOUT OCEAN UNIVERSITY OF CHINA
Ocean University of China, located in Qingdao, is one of the top universities
in China. It is considered a leader in research in the area of marine
pharmaceutical science, and has received numerous awards for its work. The
University has undertaken a large number of research papers and made great
contributions to the construction of the marine-based economy of Shandong
Province, including projects such as the seawater aquaculture. Ocean
University has been ranked No. 8 in terms of the number of prizes won for
science and technology advancement awarded by the Ministry of Education. For
more information visit www.ouc.edu.cn/english.

CONTACT:

USA:
Bob Giargiari, MBA, EVP Finance & CFO
HUYA Bioscience International, LLC
(858) 798-8800
bgiargiari@huyabio.com

China:
Qing (Vicky) Xia, Scientific Research Manager
HUYA Bioscience International, LLC
86 (21) 51323312
vxia@huyabio.com

Media Contact:
Juliet Travis
(510) 452-3771
juliet@travispr.com

SOURCE HUYA Bioscience International

USA: Bob Giargiari, MBA, EVP Finance & CFO, +1-858-798-8800,
bgiargiari@huyabio.com, or China: Qing (Vicky) Xia, Scientific Research
Manager, +86 (21) 51323312, vxia@huyabio.com, both of HUYA Bioscience
International, LLC; or Media: Juliet Travis for HUYA Bioscience International,
LLC, +1-510-452-3771, juliet@travispr.com